Pathologists fighting COVID-19 – Columbia

Kevin A. Roth, MD, PhD
Donald W. King, MD and Mary Elizabeth King, MD.Professor of Pathology and Cell Biology
Chair, Department of Pathology and Cell Biology
Pathologist in Chief, Columbia University Medical Center
New York, NY

The Columbia University Department of Pathology and Cell Biology under the leadership of Dr. Kevin A. Roth, former Editor-in-Chief of both the Journal of Histochemistry and Cytochemistry and the American Journal of Pathology, Past President of the ASIP, as well as HCS Secretary-Treasurer and Council member, has been defining both the pathogenesis of COVID-19 and providing critical insights into its clinical management. Over the last two months, the department validated several new laboratory tests, established a COVID-19 biorepository, launched a convalescent plasma donor program, performed over fifty COVID-19 autopsies, and obtained FDA approval for a COVID-19 plasma therapy study. Members of the Columbia University Department of Pathology and Cell Biology are leading local and state-wide efforts for a safe and staged approach to operations recovery at Columbia University, New York City and New York State. 

COVID-19

COVID-19 related news